Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Pneumonia, Ventilator-associated, Pneumonia, Staphylococcal
In brief
The purpose of this study is the prevention of Staphylococcus aureus pneumonia in mechanically ventilated subjects heavily colonized with S. aureus. Staphylococcus aureus is a human pathogenic bacterium that causes severe infections, including pneumonia and sepsis. Hospital-acquired bacterial pneumonia (HABP) caused by S. aureus, including ventilator-associated bacterial pneumonia (VABP) in mechanically ventilated subjects, is a significant public health threat despite efforts to optimize antibiotic treatment. ASN100 is an investigational monoclonal antibody product that targets the toxins produced by S. aureus to protect subjects from developing S. aureus pneumonia.
Key facts
- Study ID
- NCT02940626
- Run by
- Arsanis, Inc.
- People needed
- 155
- Starts
- 2016-11-01
- Expected to finish
- 2018-09-28
- Last updated by the study team
- 2019-07-31
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject is currently hospitalized and is mechanically ventilated endotracheally (i.e., orotracheal or nasotracheal) and, in the Investigator's opinion, will require ongoing ventilator support for at least 48 hours;
You may not qualify if…
- Subject has a chest X-ray or thoracic computed tomography (CT) scan that is definitive for a diagnosis of pneumonia
- Subject has a known and documented ETA culture showing heavy colonization with a -Gram-negative organism at enrollment or at any time during the Screening period;
- Significant Neutropenia
- Severe non-pulmonary source of infection.
- Subjects with a known history or current (suspected) diagnosis of cytokine release syndrome associated with the administration of peptides, proteins, and/or antibodies.
Where it is running
- Research Site — Sacramento, California, United States
- Research Site — San Francisco, California, United States
- Research Site — Aurora, Colorado, United States
- Research Site — Chicago, Illinois, United States
- Research Site — Chicago, Illinois, United States
- Research Site — Georgetown, Kentucky, United States
- Research Site — Hazard, Kentucky, United States
- Research Site — Burlington, Massachusetts, United States
- Research Site — St Louis, Missouri, United States
- Research Site — Buffalo, New York, United States
- Research Site — Charlotte, North Carolina, United States
- Research Site — Cleveland, Ohio, United States
- Research Site — Pittsburgh, Pennsylvania, United States
- Research Site — Chattanooga, Tennessee, United States
- Research Site — Memphis, Tennessee, United States
- Research Site — Dallas, Texas, United States
- Research Site 040-001 — Vienna, Austria
- Research Site 040-002 — Vienna, Austria
- Research Site — Prague, Czechia
- Research Site — Prague, Czechia
- Research Site — Argenteuil, France
- Research Site — Lille, France
- Research Site — Limoges, France
- Research Site 268-007 — Rustavi, Georgia
- Research Site — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.